Barclays analyst Gaurav Jain upgraded Scotts Miracle-Gro to Overweight from Equal Weight with an unchanged price target of $75. The analyst expects Scotts to “delever rapidly from here,” even under a wide range of macro scenarios. Over the next three years, the company should deliver $6-$8 per share in free cash flow, Jain tells investors in a research note. The analyst cites the stock’s 16% free cash flow yield for the upgrade.